Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Bobby Gaspar
CEO | Chief Executive Officer | 60 | 01/01/15 |
Frank Thomas
PSD | President | 54 | 01/01/18 |
Leslie Meltzer
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/18 |
Nicoletta Loggia
CTO | Chief Tech/Sci/R&D Officer | - | 09/09/21 |
Fulvio Mavilio
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/22 |
Renee T. Leck
IRC | Investor Relations Contact | - | - |
Christopher York
SEC | Corporate Secretary | - | - |
Braden Parker
PRN | Corporate Officer/Principal | - | - |
John Cerio
HRO | Human Resources Officer | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Abdul Mullick
BRD | Director/Board Member | - | 24/01 |
Yasuo Fujii
BRD | Director/Board Member | - | 24/01 |
60 | - | ||
Director/Board Member | 62 | 24/01 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 126 572 749 | 81 786 701 ( 64,62 %) | 0 | 64,62 % |
Coordinate società
Orchard Therapeutics Plc
245 Hammersmith Road 3rd Floor
W6 8PW, London
+44 20 3 808 8286
http://www.orchard-tx.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+31,52% | 690 Mrd | |
+21,96% | 546 Mrd | |
-5,21% | 358 Mrd | |
+17,02% | 323 Mrd | |
+5,01% | 287 Mrd | |
+13,68% | 235 Mrd | |
+3,81% | 199 Mrd | |
-10,63% | 195 Mrd | |
+3,98% | 161 Mrd |